AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Recruiting · NCT07454642 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cervical adenocarcinoma, cervical adenosquamous carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, gastric adenocarcinoma, intestinal disorder, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, vulvar adenocarcinoma | Recruiting | Phase 1 | 2026-10-05 | NCT07454642 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Avacta Life Sciences Ltd | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Florida Cancer Specialists and Research Institute | Sarasota | United States | 3 |
| Honor Health Research Institute | Scottsdale | United States | 17 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| NEXT Oncology | Irving | United States | 11 |
| NEXT Oncology Virginia | Fairfax | United States | 40 |
| START Midwest | Grand Rapids | United States | 79 |
| The University of Chicago | Chicago | United States | 65 |